Epidemiology of giant cell arteritis in an Arab population: A 22-year study

British Journal of Ophthalmology

Volumn 91, Issue 6, 2007, Pages 705-706

  Miller, Neil R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARAB; DNA POLYMORPHISM; EDITORIAL; ENVIRONMENTAL FACTOR; GIANT CELL ARTERITIS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MORBIDITY; MYCOPLASMA PNEUMONIA; PARAINFLUENZA VIRUS 1; PARVOVIRUS; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAUDI ARABIA; VARICELLA ZOSTER VIRUS;

ARABS; HUMANS; INCIDENCE; PREVALENCE; SAUDI ARABIA; TEMPORAL ARTERITIS;

EID: 34249785087     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.114017     Document Type: Editorial

References (30)

1. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: a prospective investigation, 1982-1985. Arthritis Rheum 1987;30:294-9.
2. Nohorp S, Svennson B. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community. Clin Exp Rheumatol 1991;9:351-5.
3. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 1992;19:273-6.
4. Baldursson O, Steinsson K, Bjornsson J, et al. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 1994;37:1007-12.
5. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in me county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol 1997;24:1739-43.
6. Haugeberg G, Paulsen PQ, Bie RB. Temporal arteritis in Vest Agder County in Southern Norway: incidence and clinical findings. J Rheumatol 2000;27:2624-7.
7. Salvarani C, Crowson CS, O'Fallon WM, et al. Reappraisal of the epidemiology of giant cell arteritis in Olmstead County, Minnesota, over a 50-year period. Arthritis Rheum 2004;51:264-8.
8. Sonnenblick M, Nesher G, Friedlander Y, et al. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 1994;33:938-41.
9. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, et al. Epidemiology of biopsy-proven giant cell arteritis in northeastern Spain: trend over an 18-year period. Ann Rheum Dis 2001;60:367-71.
10. Salvarani C, Macchioni P, Zizzi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991;34:351-6.
11. Kobayashi S, Yano T, Matsumoto Y, et al. Clinical and epidemiological analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 2003;49:594-8.
12. Chaudhry IA, Shamsi FA, Elzaridi E, et al. Epidemiology of giant cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol 2007;91:715-8.
13. Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology [Oxford), 2003;42:413-21.
14. Gonzalez-Gay MA, Boiardi L, Garcia-Porrua C, et al. Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in Southern Europe. J Rheumatol 2004;31:520-3.
15. Watts RA, Gonzalez-Gay MA, Garcia-Porrua C, et al. Geoepidemiology of systemic vasculitis. Ann Rheum Dis 2001;60:170-2.
16. Richardson JE, Gladman DD, Fam A, et al. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987;30:1293-7.
17. Weyand CM, Hicock KC, Hunder GG, et al. The HLADRB1 locus as a genetic component in giant cell arteritis: mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 1992;90:2355-6.
18. Weyand CM, Hunder NN, Hicok KC, et al. HLA-DRB1 alleles in polymyalgia rheumatica syndrome, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
19. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, et al. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HIA class II association. J Rheumatol 1998;25:2140-5.
20. Gonzalez-Gay MA, Rueda B, Vilchez JR, et al. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Rheumatology (Oxford), 2007;46:431-4.
21. Gonzalez-Gay MA. Genetic epidemiology in giant cell arteritis and polymyalgia rheumatica. Arthritis Res 2001;3:154-7.
22. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, et al. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003;33:38-48.
23. Duhaut P, Bosshard S, Ducroix JP. Is giant cell arteritis an infectious disease? Biological and epidemiological evidence. Presse Med 2004;33:1403-8.
24. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006;65:1093-8.
25. Elling P, Ollson AT, Elling H. Synchronous variations of incidence or temporal arteritis and polymyalgia rheumatica in different regions of Denmark; associations with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-19.
26. Elling H, Olsson AT, Elling P. Human parvovirus and giant cell areteritis: a selective arteritic impact? Clin Exp Rheumatol 2000;18(Suppl 20):12-14.
27. Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, et al. Varicella zoster virus, a cause of waxing and waning vasculitis. NEJM case 5-1995 revisited. Neurology 1996;47:1441-6.
28. Al-Abdulla NA, Rismondo V, Minkowski JS, et al. Herpes zoster vasculitis presenting as giant cell arteritis with bilateral internuclear ophthalmoplegia. Am J Ophthalmol 2002;134:912-14.
29. Nordborg C, Nordborg E, Petursdottir V, et al. Search for varicella zoster virus in giant cell arteritis. Ann Neurol 1998;44:413-14.
30. Gordon LK, Goldman M, Sandusky H, et al. Identification of candidate microbial sequences from inflammatory lesions of giant cell arteritis. Clin Immunol 2004;111:286-96.